Skip to main content
. 2019 Apr 29;78(8):1122–1126. doi: 10.1136/annrheumdis-2019-215086

Table 2.

Association between inactivated influenza vaccine, vasculitis and unexplained fever*

Outcome Risk period Events (n) Person-time (days) Incidence rate ratio (95% CI) P values
Vasculitis
Unexposed 89 30 936 1.00 0.906
15 days prevaccination 5 1815 0.95 (0.38 to 2.33)
Postvaccination intervals
0–14 days X1 1694 0.41 (0.10 to 1.65) 0.207
15–30 days 5 1815 0.95 (0.38 to 2.33) 0.906
31–60 days 8 3630 0.76 (0.37 to 1.56) 0.453
61–90 days 12 3630 1.14 (0.62 to 2.08) 0.677
Unexplained Unexposed 92 30 735 1.00 0.507
Fever
15 days prevaccination X1 1819 0.71 (0.26 to 1.94)
Postvaccination intervals
0–14 days X1 1708 0.71 (0.26 to 1.94) 0.589
15–30 days 6 1830 1.06 (0.28 to 2.07) 0.887
31–60 days 5 3650 0.45 (0.18 to 1.10) 0.079
61–90 days 12 3630 1.09 (0.60 to 1.99) 0.780

X1 fewer than five events in each cell, data suppressed according to Clinical Practice Research Datalink policy.

*Unexplained fever was defined as fever not due to a known cause, for example, infection.